PRRT2 and Alzheimer disease: They found progressive modulation of τ and amyloid precursor protein (APP) interactomes, early disruption of upstream and downstream p38 MAPK pathway, and subsequent impairment of protein kinase C (PKC) signaling axis in the OB from AD subjects.